Matches in SemOpenAlex for { <https://semopenalex.org/work/W935432932> ?p ?o ?g. }
- W935432932 endingPage "95.e7" @default.
- W935432932 startingPage "95.e1" @default.
- W935432932 abstract "This study aims to assess the nephrotoxicity and efficacy of tenofovir disoproxil fumarate (tenofovir), telbivudine and entecavir. A retrospective study of 587 patients with chronic hepatitis B treated with tenofovir (n = 170), telbivudine (n = 184) and entecavir (n = 233) for at least 1 year. Renal function and efficacy were assessed. The estimated glomerular filtration rate (eGFR) decreased significantly in the tenofovir group after a mean of 17 months treatment (from 92.2 to 85.6 mL/min/1.73 m2, p < 0.001), but increased in the telbivudine group after a mean of 32 months of treatment (from 86.1 to 95 mL/min/1.73 m2, p < 0.001). There was no significant change in eGFR in the entecavir group after a mean of 44 months. By multivariate analysis, pre-existing renal insufficiency (p = 0.003), tenofovir (p = 0.007) and diuretic treatment (p = 0.001) were independent predictors for renal function deterioration. Cumulative virological breakthrough was 0% in tenofovir after 2 years, 3.4% in entecavir after 7 years and 22.9% in telbivudine after 5 years. Liver cirrhosis (p = 0.008) and virological breakthrough (p = 0.040) were independently associated with increased risk of hepatocellular carcinoma development. Tenofovir may lead to deterioration in renal function as assessed by serial eGFR measurements. Although telbivudine appeared to be associated with an improvement in eGFR, it was associated with high rates of virological breakthrough, which was an independent risk factor for HCC development. With low rates of virological breakthrough and preservation of renal function, entecavir could be the best choice among these three agents." @default.
- W935432932 created "2016-06-24" @default.
- W935432932 creator A5003451839 @default.
- W935432932 creator A5008054592 @default.
- W935432932 creator A5009051044 @default.
- W935432932 creator A5009773359 @default.
- W935432932 creator A5010318588 @default.
- W935432932 creator A5013407056 @default.
- W935432932 creator A5014701689 @default.
- W935432932 creator A5036225505 @default.
- W935432932 creator A5040030545 @default.
- W935432932 creator A5043140399 @default.
- W935432932 creator A5076367211 @default.
- W935432932 creator A5081103030 @default.
- W935432932 creator A5091863351 @default.
- W935432932 date "2016-01-01" @default.
- W935432932 modified "2023-10-18" @default.
- W935432932 title "Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience" @default.
- W935432932 cites W1515482738 @default.
- W935432932 cites W1881193782 @default.
- W935432932 cites W1962312697 @default.
- W935432932 cites W1963664285 @default.
- W935432932 cites W1999882842 @default.
- W935432932 cites W2005270107 @default.
- W935432932 cites W2005654409 @default.
- W935432932 cites W2009474584 @default.
- W935432932 cites W2031317669 @default.
- W935432932 cites W2056779298 @default.
- W935432932 cites W2059560167 @default.
- W935432932 cites W2071766135 @default.
- W935432932 cites W2088305891 @default.
- W935432932 cites W2093278852 @default.
- W935432932 cites W2093416429 @default.
- W935432932 cites W2101809540 @default.
- W935432932 cites W2107027814 @default.
- W935432932 cites W2128084020 @default.
- W935432932 cites W2182813120 @default.
- W935432932 cites W2393327590 @default.
- W935432932 cites W288071694 @default.
- W935432932 cites W4211026375 @default.
- W935432932 doi "https://doi.org/10.1016/j.cmi.2015.05.035" @default.
- W935432932 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26055419" @default.
- W935432932 hasPublicationYear "2016" @default.
- W935432932 type Work @default.
- W935432932 sameAs 935432932 @default.
- W935432932 citedByCount "45" @default.
- W935432932 countsByYear W9354329322016 @default.
- W935432932 countsByYear W9354329322017 @default.
- W935432932 countsByYear W9354329322018 @default.
- W935432932 countsByYear W9354329322019 @default.
- W935432932 countsByYear W9354329322020 @default.
- W935432932 countsByYear W9354329322021 @default.
- W935432932 countsByYear W9354329322022 @default.
- W935432932 countsByYear W9354329322023 @default.
- W935432932 crossrefType "journal-article" @default.
- W935432932 hasAuthorship W935432932A5003451839 @default.
- W935432932 hasAuthorship W935432932A5008054592 @default.
- W935432932 hasAuthorship W935432932A5009051044 @default.
- W935432932 hasAuthorship W935432932A5009773359 @default.
- W935432932 hasAuthorship W935432932A5010318588 @default.
- W935432932 hasAuthorship W935432932A5013407056 @default.
- W935432932 hasAuthorship W935432932A5014701689 @default.
- W935432932 hasAuthorship W935432932A5036225505 @default.
- W935432932 hasAuthorship W935432932A5040030545 @default.
- W935432932 hasAuthorship W935432932A5043140399 @default.
- W935432932 hasAuthorship W935432932A5076367211 @default.
- W935432932 hasAuthorship W935432932A5081103030 @default.
- W935432932 hasAuthorship W935432932A5091863351 @default.
- W935432932 hasBestOaLocation W9354329321 @default.
- W935432932 hasConcept C126322002 @default.
- W935432932 hasConcept C159047783 @default.
- W935432932 hasConcept C159641895 @default.
- W935432932 hasConcept C2522874641 @default.
- W935432932 hasConcept C2776175608 @default.
- W935432932 hasConcept C2777382497 @default.
- W935432932 hasConcept C2777869810 @default.
- W935432932 hasConcept C2778019345 @default.
- W935432932 hasConcept C2779344132 @default.
- W935432932 hasConcept C2781144229 @default.
- W935432932 hasConcept C2992208098 @default.
- W935432932 hasConcept C3013748606 @default.
- W935432932 hasConcept C3020491458 @default.
- W935432932 hasConcept C71924100 @default.
- W935432932 hasConcept C90924648 @default.
- W935432932 hasConceptScore W935432932C126322002 @default.
- W935432932 hasConceptScore W935432932C159047783 @default.
- W935432932 hasConceptScore W935432932C159641895 @default.
- W935432932 hasConceptScore W935432932C2522874641 @default.
- W935432932 hasConceptScore W935432932C2776175608 @default.
- W935432932 hasConceptScore W935432932C2777382497 @default.
- W935432932 hasConceptScore W935432932C2777869810 @default.
- W935432932 hasConceptScore W935432932C2778019345 @default.
- W935432932 hasConceptScore W935432932C2779344132 @default.
- W935432932 hasConceptScore W935432932C2781144229 @default.
- W935432932 hasConceptScore W935432932C2992208098 @default.
- W935432932 hasConceptScore W935432932C3013748606 @default.
- W935432932 hasConceptScore W935432932C3020491458 @default.
- W935432932 hasConceptScore W935432932C71924100 @default.